Skip to main content
. 2024 May 9;14(5):1315–1325. doi: 10.1007/s13555-024-01177-1

Table 1.

Demographic data of participants

Treatment group Female/male (n) Mean age ± SD (years)
IncobotulinumtoxinA (IncoA) 7/3 36.8 ± 4.69
OnabotulinumtoxinA (OnaA) 5/5 32.5 ± 4.59
AbobotulinumtoxinA (AboA) 10/0 38.3 ± 7.94
PrabotulinumtoxinA (PraboA) 8/2 39 ± 5.18
LetibotulinumtoxinA (LetiA) 9/1 33.9 ± 5.15

SD Standard deviation